A significant recall of a widely used blood pressure medication has been issued, affecting approximately 600,000 bottles. The recall is a precautionary measure due to concerns over possible contamination, stemming from an unregulated manufacturer’s use of questionable ingredients.
The medication in question is Ramipril, a commonly prescribed treatment for hypertension. It works by opening up blood vessels and reducing heart pressure, often administered to patients who have suffered a heart attack. The recall affects Ramipril capsules in strengths of 2.5 mg, 5 mg, and 10 mg.
An investigation revealed that one of the ingredients was sourced from a factory in India, which had inadequate quality control measures in place. Although the FDA considers the risk of contamination to be low, they are taking a cautious approach to ensure public safety. Fortunately, there have been no reported adverse effects thus far.
If you are taking Ramipril, it is essential to check your medication to see if it is part of the recall. The affected bottles were manufactured by Lupin Pharmaceuticals, an Indian company, and come in strengths of 2.5 mg, 5 mg, and 10 mg. The recalled bottles have a sell-by date up to July 2026 and are packaged in bottles of 90, 10, and 150. If you have a recalled bottle, it is best to discard it immediately.
